Life Science

Going to be an interesting day. I’m attending a conference at Stanford U entitled "Realizing the Promise: Early Detection of Cancer."  Pat Felts, Dr. Georjean Stoodt, and Dr. Cynthia LeBlanc and a cadre of California Division and NHO staff are here as well. The spark-plug for the conference is Dr. Lee Hartwell, ACS Professor, Medal of Honor winner and Nobel ...

About everybody feels it’s a good idea to convert paper medical records to electronic ones. Should be more efficient and, hopefully, accurate. The problem is it’s hell getting there. This article covers most of the problems. One problem is cost; the cost of systems and labor to convert records is prohibitive for small practices.One solution to this is to have ...

Yesterday Lorraine Thompson and I attended the BayBio annual conference for biotech companies. BayBio is the SF Bay Area biotech trade group. We attended to network with people in the industry. I’m on the organization’s Patient Advocacy Committee. We’re looking for an appropriate working relationship between nonprofit organizations and biotech companies that supports both the goals of disease-oriented organizations and ...

I’m sure everybody’s seen the news that Herceptin when used with chemotherapy has been shown to be effective enough in preventing recurrence of breast cancer that they halted the study early. Might as  well get on with it. But what caught my attention was the following remark: The apparent success of Herceptin validates the strategy of cancer researchers to study ...